857 |
CABG Is Still the First Line Therapy |
David Paul Taggart |
Jul. 21. 09 |
856 |
Ten Year Results of the LE MANS Registry |
Pawel E. Buszman |
Jul. 21. 09 |
855 |
Can SYNTAX Score Be Feasible to Predict Outcomes of LM Revascularization?: Application to MAIN-COMPARE Registry |
Seung-Jung Park |
Jul. 21. 09 |
854 |
Long-Term Outcomes of Left Main French Taxus Registry |
Thierry Lefevre |
Jul. 21. 09 |
853 |
Perspective of LM Stenting with Current Registry and Randomized Clinical Data |
Patrick W. Serruys |
Jul. 21. 09 |
852 |
SYNTAX LM & Bifurcation: Classification & Outcomes |
Keith D. Dawkins |
Jul. 21. 09 |
851 |
Can High Risk of LM Revascularization Be Identified with Preoperational Clinical and Angiographic Characteristics?: LM-SCORE |
Young-Hak Kim |
Jul. 21. 09 |
850 |
Customized Technique of Left Main Stenting According to Anatomical Characteristics |
Alaide Chieffo |
Jul. 21. 09 |
849 |
Next Generation on PAVR Technologies |
Eberhard Grube |
Jul. 21. 09 |
848 |
Percutaneous Aortic Valve Replacement with the CoreValve System |
Raoul Bonan |
Jul. 21. 09 |